Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes

Roberto Pecoits-Filho^{1

2}, Ikechi G Okpechi^{3

4}, Jo-Ann Donner⁵, David C H Harris⁶, Harith M Aljubori⁷, Aminu K Bello⁸, Ezequiel Bellorin-Font⁹, Fergus J Caskey^{10

11

12}, Allan Collins^{13

14}, Alfonso M Cueto-Manzano¹⁵, John Feehally¹⁶, Bak Leong Goh¹⁷, Kitty J Jager¹⁸, Masaomi Nangaku¹⁹, Muhibur Rahman²⁰, Manisha Sahay²¹, Abdulkarim Saleh²², Laura Sola²³, Rumeyza Turan Kazancioglu^{24

25}, Rachael C Walker^{24

25

26}, Robert Walker²⁷, Qiang Yao²⁸, Xueqing Yu^{29

30}, Ming-Hui Zhao^{31

32

33

34}, David W Johnson^{35

36

37}

Affiliations

¹ School of Medicine, Pontificia Universidade Catolica do Paraná, Curitiba, Brazil.
² Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
³ Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa.
⁴ Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa.
⁵ International Society of Nephrology, Brussels, Belgium.
⁶ Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
⁷ Nephrology Department, Alqassimi Hospital, Sharjah, United Arab Emirates.
⁸ Division of Nephrology and Immunity, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
⁹ Division of Nephology and Hypertension, Department of Medicine, Saint Louis University, Saint Louis, Missouri, USA.
¹⁰ UK Renal Registry, Learning and Research, Southmead Hospital, Bristol, UK.
¹¹ Population Health Sciences, University of Bristol, Bristol, UK.
¹² The Richard Bright Renal Unit, Southmead Hospital, North Bristol National Health Service Trust, Bristol, UK.
¹³ NxStage Medical, Inc., Lawrence, Massachusetts, USA.
¹⁴ Department of Medicine, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA.
¹⁵ Unidad de Investigación Médica en Enfermedades Renales, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México.
¹⁶ University of Leicester, Leicester, UK.
¹⁷ Department of Nephrology and Clinical Research Centre, Hospital Serdang, Jalan Puchong, Kajang, Selangor, Malaysia.
¹⁸ European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands.
¹⁹ Division of Nephrology, The University of Tokyo School of Medicine, Hongo, Japan.
²⁰ Department of Nephrology, Sir Salimullah Medical College and Mitford Hospital, Dhaka, Bangladesh.
²¹ Department of Nephrology, Osmania Medical College and General Hospital, Hyderabad, Telangana, India.
²² Department of Nephrology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
²³ Dialysis Unit, Centro Asistencial del Sindicato Médico del Uruguay Institución de Asistencia Médica Privada de Profesionales Sin Fines de lucro, Montevideo, Uruguay.
²⁴ Division of Nephrology, Bezmialem Vakif University, Istanbul, Turkey.
²⁵ Walker, School of Nursing, Eastern Institute of Technology, Napier, New Zealand.
²⁶ Renal Department, Hawke's Bay District Health Board, Hastings, New Zealand.
²⁷ Department of Medicine, University of Otago, Dunedin, New Zealand.
²⁸ Medical Affairs, Baxter Healthcare, Guangzhou, China.
²⁹ Division of Nephrology, Guangdong Provincial People's School of Medicine, South China University of Technology, Guangzhou, China.
³⁰ Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
³¹ Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
³² Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
³³ Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing, China.
³⁴ Peking-Tsinghua Center for Life Sciences, Beijing, China.
³⁵ Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia.
³⁶ Translational Research Institute, Brisbane, Australia.
³⁷ Metro South and Ipswich Nephrology and Transplant Services, Princess Alexandra Hospital, Brisbane, Australia.

PMID: 32149004
PMCID: PMC7031690
DOI: 10.1016/j.kisu.2019.11.001

Review

Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes

Roberto Pecoits-Filho et al. Kidney Int Suppl (2011). 2020 Mar.

. 2020 Mar;10(1):e3-e9.

doi: 10.1016/j.kisu.2019.11.001. Epub 2020 Feb 19.

Authors

Affiliations

¹ School of Medicine, Pontificia Universidade Catolica do Paraná, Curitiba, Brazil.
² Arbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
³ Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa.
⁴ Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa.
⁵ International Society of Nephrology, Brussels, Belgium.
⁶ Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
⁷ Nephrology Department, Alqassimi Hospital, Sharjah, United Arab Emirates.
⁸ Division of Nephrology and Immunity, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
⁹ Division of Nephology and Hypertension, Department of Medicine, Saint Louis University, Saint Louis, Missouri, USA.
¹⁰ UK Renal Registry, Learning and Research, Southmead Hospital, Bristol, UK.
¹¹ Population Health Sciences, University of Bristol, Bristol, UK.
¹² The Richard Bright Renal Unit, Southmead Hospital, North Bristol National Health Service Trust, Bristol, UK.
¹³ NxStage Medical, Inc., Lawrence, Massachusetts, USA.
¹⁴ Department of Medicine, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA.
¹⁵ Unidad de Investigación Médica en Enfermedades Renales, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México.
¹⁶ University of Leicester, Leicester, UK.
¹⁷ Department of Nephrology and Clinical Research Centre, Hospital Serdang, Jalan Puchong, Kajang, Selangor, Malaysia.
¹⁸ European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands.
¹⁹ Division of Nephrology, The University of Tokyo School of Medicine, Hongo, Japan.
²⁰ Department of Nephrology, Sir Salimullah Medical College and Mitford Hospital, Dhaka, Bangladesh.
²¹ Department of Nephrology, Osmania Medical College and General Hospital, Hyderabad, Telangana, India.
²² Department of Nephrology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
²³ Dialysis Unit, Centro Asistencial del Sindicato Médico del Uruguay Institución de Asistencia Médica Privada de Profesionales Sin Fines de lucro, Montevideo, Uruguay.
²⁴ Division of Nephrology, Bezmialem Vakif University, Istanbul, Turkey.
²⁵ Walker, School of Nursing, Eastern Institute of Technology, Napier, New Zealand.
²⁶ Renal Department, Hawke's Bay District Health Board, Hastings, New Zealand.
²⁷ Department of Medicine, University of Otago, Dunedin, New Zealand.
²⁸ Medical Affairs, Baxter Healthcare, Guangzhou, China.
²⁹ Division of Nephrology, Guangdong Provincial People's School of Medicine, South China University of Technology, Guangzhou, China.
³⁰ Key Laboratory of Nephrology, Ministry of Health, Guangzhou, Guangdong, China.
³¹ Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
³² Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
³³ Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing, China.
³⁴ Peking-Tsinghua Center for Life Sciences, Beijing, China.
³⁵ Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia.
³⁶ Translational Research Institute, Brisbane, Australia.
³⁷ Metro South and Ipswich Nephrology and Transplant Services, Princess Alexandra Hospital, Brisbane, Australia.

PMID: 32149004
PMCID: PMC7031690
DOI: 10.1016/j.kisu.2019.11.001

Abstract

A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one-half to three-quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that >3 million people in the world died each year because they could not access KRT. This review discusses the reasons for the differences in treated and untreated ESKD and KRT modalities and outcomes and presents strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.

Keywords: end-stage kidney disease; global health; health information systems; health services accessibility; kidney replacement therapy; registries.

PubMed Disclaimer

Figures

**Figure 1**
**Availability of renal (dialysis and transplantation) registries across the globe.** Reprinted with permission from See EJ, Alrukhaimi M, Ashuntantang GE, et al. Global coverage of health information systems for kidney disease: availability, challenges, and opportunities for development. *Kidney Int Suppl.* 2018;8:74–81. N/A, information not available.

See this image and copyright information in PMC

Comment in

The second Global Kidney Health Summit outputs: developing a strategic plan to increase access to integrated end-stage kidney disease care worldwide.
Harris DCH, Davies SJ, Finkelstein FO, Jha V. Harris DCH, et al. Kidney Int Suppl (2011). 2020 Mar;10(1):e1-e2. doi: 10.1016/j.kisu.2019.09.001. Epub 2020 Feb 19. Kidney Int Suppl (2011). 2020. PMID: 32154795 Free PMC article. No abstract available.

References

1. Couser W.G., Remuzzi G., Mendis S. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80:1258–1270. - PubMed
1. Neuen B.L., Chadban S., Demaio A.R. Chronic kidney disease and the global NCDs agenda. BMJ Global Health. 2017;2 - PMC - PubMed
1. Jager K.J., Fraser S.D.S. The ascending rank of chronic kidney disease in the global burden of disease study. Nephrol Dial Transplant. 2017;32(suppl 2):ii121–ii128. - PubMed
1. BD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544. - PMC - PubMed
1. Luyckx V.A., Miljeteig I., Ejigu A.M. Ethical challenges in the provision of dialysis in resource-constrained environments. Semin Nephrol. 2017;37:273–286. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes

Affiliations

Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes

Authors

Affiliations

Abstract

Figures

Comment in

References

Publication types

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous